Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Beatriz Galván is active.

Publication


Featured researches published by Beatriz Galván.


Critical Care | 2009

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

Jordi Rello; Alejandro Rodríguez; Pedro Ibañez; Lorenzo Socias; Javier Cebrian; Asunción Marques; José Antonio Chamizo Guerrero; Sergio Ruiz-Santana; Enrique Márquez; Frutos Del Nogal-Saez; Francisco Álvarez-Lerma; Sergio F. Martínez; Miquel Ferrer; Manuel Avellanas; Rosa María Granada; Enrique Maraví-Poma; Patricia Albert; Rafael Sierra; Loreto Vidaur; Patricia Ortiz; Isidro Prieto del Portillo; Beatriz Galván; Cristóbal León-Gil

IntroductionPatients with influenza A (H1N1)v infection have developed rapidly progressive lower respiratory tract disease resulting in respiratory failure. We describe the clinical and epidemiologic characteristics of the first 32 persons reported to be admitted to the intensive care unit (ICU) due to influenza A (H1N1)v infection in Spain.MethodsWe used medical chart reviews to collect data on ICU adult patients reported in a standardized form. Influenza A (H1N1)v infection was confirmed in specimens using real-time reverse transcriptase-polymerase-chain-reaction (RT PCR) assay.ResultsIllness onset of the 32 patients occurred between 23 June and 31 July, 2009. The median age was 36 years (IQR = 31 - 52). Ten (31.2%) were obese, 2 (6.3%) pregnant and 16 (50%) had pre-existing medical complications. Twenty-nine (90.6%) had primary viral pneumonitis, 2 (6.3%) exacerbation of structural respiratory disease and 1 (3.1%) secondary bacterial pneumonia. Twenty-four patients (75.0%) developed multiorgan dysfunction, 7 (21.9%) received renal replacement techniques and 24 (75.0%) required mechanical ventilation. Six patients died within 28 days, with two additional late deaths. Oseltamivir administration delay ranged from 2 to 8 days after illness onset, 31.2% received high-dose (300 mg/day), and treatment duration ranged from 5 to 10 days (mean 8.0 ± 3.3).ConclusionsOver a 5-week period, influenza A (H1N1)v infection led to ICU admission in 32 adult patients, with frequently observed severe hypoxemia and a relatively high case-fatality rate. Clinicians should be aware of pulmonary complications of influenza A (H1N1)v infection, particularly in pregnant and young obese but previously healthy persons.


Critical Care Medicine | 2009

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

Cristóbal León; Sergio Ruiz-Santana; Pedro Saavedra; Beatriz Galván; Armando Blanco; Carmen Castro; Carina Balasini; Aránzazu Utande-Vázquez; Francisco Molina; Miguel A. Blasco-Navalproto; Maria J. López; Pierre Emmanuel Charles; Estrella Martín; María Adela Hernández-Viera

Objective:To assess the usefulness of the “Candida score” (CS) for discriminating between Candida species colonization and invasive candidiasis (IC) in non-neutropenic critically ill patients. A rate of IC <5% in patients with CS <3 was the primary end point. Design:Prospective, cohort, observational study. Setting:Thirty-six medical-surgical intensive care units of Spain, Argentina, and France. Patients:A total of 1,107 non-neutropenic adult intensive care unit patients admitted for at least 7 days between April 2006 and June 2007. Measurements and Main Results:Clinical data, surveillance cultures for fungal growth, and serum levels of (1–3)-beta-d-glucan and anti-Candida antibodies (in a subset of patients) were recorded. The CS was calculated as follows (variables coded as absent = 0, present = 1): total parenteral nutrition ×1, plus surgery ×1, plus multifocal Candida colonization ×1, plus severe sepsis ×2. A CS ≥3 accurately selected patients at high risk for IC. The colonization index was registered if ≥0.5. The rate of IC was 2.3% (95% confidence interval [CI] 1.06–3.54) among patients with CS <3, with a linear association between increasing values of CS and IC rate (p ≤ 0.001). The area under the receiver operating characteristic curve for CS was 0.774 (95% CI 0.715–0.832) compared with 0.633 (95% CI 0.557–0.709) for CI. (1–3)-Beta-d-glucan was also an independent predictor of IC (odds ratio 1.004, 95% CI 1.0–1.007). The relative risk for developing IC in colonized patients without antifungal treatment was 6.83 (95% CI 3.81–12.45). Conclusions:In this cohort of colonized patients staying >7 days, with a CS <3 and not receiving antifungal treatment, the rate of IC was <5%. Therefore, IC is highly improbable if a Candida-colonized non-neutropenic critically ill patient has a CS <3.


Journal of Antimicrobial Chemotherapy | 2014

Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance

Elena López-Camacho; Rosa Gómez-Gil; Raquel Tobes; Marina Manrique; María Lorenzo; Beatriz Galván; Estefanía Salvarelli; Youssef Moatassim; Iñigo J. Salanueva; Eduardo Pareja; Francisco M. Codoñer; Miguel Alvarez-Tejado; Maria Pilar Garcillán-Barcia; Fernando de la Cruz; Jesús Mingorance

OBJECTIVES To characterize at the genomic level the evolution of multiresistance during an outbreak of Klebsiella pneumoniae in a burns intensive care unit. The outbreak involved a DHA-1 β-lactamase-producing strain that later acquired carbapenem and fosfomycin resistance, and in one case colistin resistance. METHODS The genomes of two isolates were sequenced and compared with a previously sequenced genome. The role of hypermutability was investigated by measuring the mutation frequencies of the isolates and comparison with a collection of control strains. RESULTS Sequence comparison identified four single-nucleotide variants and two transposon insertions. Analysis of the variants in the whole collection related carbapenem and fosfomycin resistance to a nonsense mutation in the ompK36 porin gene and colistin resistance to an IS1 insertion in the mgrB gene. The plasmid carrying the blaDHA-1 gene was unstable in the absence of antibiotics, and analysis of isolates that had lost the plasmid showed that the porin mutation alone was not sufficient to generate carbapenem resistance. The mutation frequencies were similar among all the strains analysed. CONCLUSIONS Carbapenem resistance required production of the DHA-1 β-lactamase and decreased permeability, but fosfomycin resistance depended only on permeability. Resistance to colistin might be related to an alteration in the regulation of the phoPQ system. Hypermutation is not related to the selection of porin mutants. Plasmid instability might be due to the high number of mobile elements and suggests a major role for antibiotic selection pressure in the emergence and evolution of this outbreak.


Critical Care | 2013

A protocol for resuscitation of severe burn patients guided by transpulmonary thermodilution and lactate levels: a 3-year prospective cohort study

Manuel Sanchez; Abelardo García-de-Lorenzo; Eva Pablos Herrero; Teresa López; Beatriz Galván; Mj Asensio; Lucia Cachafeiro; Cesar Casado

IntroductionThe use of urinary output and vital signs to guide initial burn resuscitation may lead to suboptimal resuscitation. Invasive hemodynamic monitoring may result in over-resuscitation. This study aimed to evaluate the results of a goal-directed burn resuscitation protocol that used standard measures of mean arterial pressure (MAP) and urine output, plus transpulmonary thermodilution (TPTD) and lactate levels to adjust fluid therapy to achieve a minimum level of preload to allow for sufficient vital organ perfusion.MethodsWe conducted a three-year prospective cohort study of 132 consecutive critically burned patients. These patients underwent resuscitation guided by MAP (>65 mmHg), urinary output (0.5 to 1 ml/kg), TPTD and lactate levels. Fluid therapy was adjusted to achieve a cardiac index (CI) >2.5 L/minute/m2 and an intrathoracic blood volume index (ITBVI) >600 ml/m2, and to optimize lactate levels. Statistical analysis was performed using mixed models. We also used Pearson or Spearman methods and the Mann-Whitney U-test.ResultsA total of 98 men and 34 women (mean age, 48 ± 18 years) was studied. The mean total body surface area (TBSA) burned was 35% ± 22%. During the early resuscitation phase, lactate levels were elevated (2.58 ± 2.05 mmol/L) and TPTD showed initial hypovolemia by the CI (2.68 ± 1.06 L/minute/m2) and the ITBVI (709 ± 254 mL/m2). At 24 to 32 hours, the CI and lactic levels were normalized, although the ITBVI remained below the normal range (744 ± 276 ml/m2). The mean fluid rate required to achieve protocol targets in the first 8 hours was 4.05 ml/kg/TBSA burned, which slightly increased in the next 16 hours. Patients with a urine output greater than or less than 0.5 ml/kg/hour did not show differences in heart rate, mean arterial pressure, CI, ITBVI or lactate levels.ConclusionsInitial hypovolemia may be detected by TPTD monitoring during the early resuscitation phase. This hypovolemia might not be reflected by blood pressure and hourly urine output. An adequate CI and tissue perfusion can be achieved with below-normal levels of preload. Early resuscitation guided by lactate levels and below-normal preload volume targets appears safe and avoids unnecessary fluid input.


Revista Iberoamericana De Micologia | 2006

Epidemiología de la candidemia en UCI

Beatriz Galván; Francisco Mariscal

During the last decades there has been an important increase in the incidence of fungal infections. These infections are common in the setting of Intensive Care Units (ICU), where the prevalence of high-risk patients is important. In this review we discuss the incidence of candidemia in ICUs, as well as the mortality and economic impact. The participation of non-Candida albicans Candida species in the etiology of these infections is currently increasing.


Burns | 2014

Prevalence of intra-abdominal hypertension (IAH) among patients with severe burns

Manuel Sánchez-Sánchez; Abelardo García-de-Lorenzo; Eva Pablos Herrero; Mj Asensio; Beatriz Galván; Lucia Cachafeiro

o solve the problem of non-availability of conventional sites or electrocardiogram (ECG) electrode placement in patients ith burn, authors have described successful use of ‘staple Panel A) [5]. The ‘left leg’ electrode was placed over burn free superior aspect of the left iliac crest [5]. The ECG tracing obtained (Fig. 1, Panel B) without any adjustment factor and in the bandwidth of 0.05–150 Hz was satisfactory (Philips Intellivue 40 monitor, Philips Medizin Systeme, Boeblingen, Germany) [5]. On examination of the ST and QT snippet, satisfactory wave morphology was observed (Fig. 1, Panel B). We have been using this technique since then. If ECG lead configuration of more than 3 leads is desirable, the description by Farroha et al. provides advantage over the technique presented by us [2]. But as ECG tracing is influenced b u r n s 4 0 ( 2 0 1 4 ) 5 2 5 – 5 3 7 32


Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia | 2013

Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient

José Garnacho-Montero; Pedro Olaechea; Francisco Álvarez-Lerma; Luis Álvarez-Rocha; José Blanquer; Beatriz Galván; Alejandro Rodríguez; Rafael Zaragoza; José-María Aguado; José Mensa; Amparo Solé; José Barberán


Revista Espanola De Quimioterapia | 2013

Epidemiología, diagnóstico y tratamiento de las infecciones fúngicas respiratorias en el paciente crítico

José Garnacho Montero; Pedro Olaechea; Francisco Alvarez Lerma; Luis Álvarez Rocha; José Blanquer; Beatriz Galván; Alejandro Rodríguez; R. Zaragoza Crespo; José María Aguado; José Mensa; Amparo Solé Jover; José Barberán


Burns | 2009

Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) in critically burn patients

M. Sanchez; Eva Pablos Herrero; Mj Asensio; P. Araujo; Beatriz Galván; R. Denia; E. Perales; E. Perez; Abelardo García-de-Lorenzo


Critical Care Medicine | 2014

101: PHARMACOKINETICS OF MICAFUNGIN IN PLASMA AND BURN ESCHARES IN CRITICALLY ILL BURNED PATIENTS

Mj Asensio; Manuel Sanchez; Beatriz Galván; Eva Pablos Herrero; Lucia Cachafeiro; Alexander Agrifolio; Sonia Luque; Abelardo García-de-Lorenzo

Collaboration


Dive into the Beatriz Galván's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eva Pablos Herrero

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar

Mj Asensio

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar

Lucia Cachafeiro

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar

Francisco Álvarez-Lerma

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

José Barberán

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José Mensa

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Manuel Sanchez

Hospital Universitario La Paz

View shared research outputs
Researchain Logo
Decentralizing Knowledge